Norepinephrine Enhances Aerobic Glycolysis and May Act as a Predictive Factor for Immunotherapy in Gastric Cancer
Open Access
- 27 March 2021
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-13
Abstract
Objective/Background and Aims. The gastrointestinal tract is rich in neurotransmitters, which play an essential role in the occurrence and development of gastrointestinal tumors. We aimed to explore the function of neurotransmitters in gastric cancer and identify a suitable target to treat gastric cancer patients in the future. Methods. Monoamine neurotransmitters were detected in gastric cancer tissue and paired normal tissue, and The Cancer Genome Atlas was used to identify differentially expressed norepinephrine-degrading and synthetic enzymes. Quantitative real-time PCR and the Seahorse assay were used to determine the effect of norepinephrine on gastric cancer cell glycolysis. MAOA expression in cancer tissues was analyzed by immunohistochemistry and was compared with the patient SUVmax value of PET-CT and other clinicopathological characteristics. Results. The norepinephrine levels were markedly high in gastric cancer tissue, while the norepinephrine-degrading enzymes MAOA and MAOB showed low expression. High norepinephrine levels were associated with activated glycolysis. The MAOA or MAOB expression levels in tumor tissue were closely correlated with the patient SUV max values of PET-CT and immunotherapy evaluation indices, such as PD-L1 and the microsatellite status. Conclusions. Norepinephrine shows relatively higher expression in gastric cancer tissue than in normal tissue, and its expression level is associated with the glycolysis levels in patients. The norepinephrine-degrading enzymes MAOA and MAOB have significant expression differences in cancer and normal tissue, and their missing or low expression may predict immune therapy outcomes for gastric cancer patients. High norepinephrine levels with metabolic abnormalities may be more suitable for metabolic targeted therapy or immunotherapy.Keywords
Funding Information
- Shanghai Jiao Tong University (YG2019QNB20)
This publication has 33 references indexed in Scilit:
- β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell linesLaboratory Investigation, 2013
- Beta blockers, norepinephrine, and cancer: an epidemiological viewpointClinical Epidemiology, 2012
- β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2011
- Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohortBreast Cancer Research and Treatment, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and MetastasisJournal of Biological Chemistry, 2010
- The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast CancerCancer Research, 2010
- Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikisJournal of Clinical Investigation, 2010
- Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progressionBrain, Behavior, and Immunity, 2009
- VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrineBrain, Behavior, and Immunity, 2008